| Literature DB >> 35202320 |
Yufei Zhao1, Yiping Zhu1, Bo Liu1, Junpeng Mi2, Nan Li1, Weisen Zhao3, Rongzheng Wu1, Gilbert Reed Holyoak4, Jing Li1, Dejun Liu1, Shenming Zeng3, Yang Wang1.
Abstract
BACKGROUND: Endometritis is a common reproductive disease in equine animals. No investigation about the bacterial characteristics and antimicrobial susceptibility pattern of donkeys with endometritis has thus far been reported.Entities:
Keywords: MDR; antimicrobial susceptibility; bacteriology; donkeys; endometritis; prevalence; subfertility
Year: 2022 PMID: 35202320 PMCID: PMC8875120 DOI: 10.3390/vetsci9020067
Source DB: PubMed Journal: Vet Sci ISSN: 2306-7381
Species and frequency of bacteria isolated from uterine swabs of 30 donkeys at ECDC between 2018 and 2021.
| Micro-Organisms | Number of Isolates | Frequency of Isolates (%) |
|---|---|---|
|
| 3 | 4.1 |
|
| 10 | 13.7 |
|
| 3 | 4.1 |
| 1 | 1.7 | |
| 1 | 1.7 | |
|
| 1 | 1.7 |
|
| 1 | 1.7 |
|
| 2 | 2.7 |
|
| 2 | 2.7 |
| 1 | 1.7 | |
| 3 | 4.1 | |
|
| 23 | 31.5 |
|
| 2 | 2.7 |
|
| 2 | 2.7 |
|
| 1 | 1.7 |
|
| 2 | 2.7 |
|
| 8 | 10.9 |
| 4 | 5.4 | |
|
| 3 | 4.1 |
| Total | 73 | 100 |
Antimicrobial susceptibility of Gram-negative bacteria isolated from the uterus of 30 donkeys at ECDC between 2018 and 2021.
| Gram-Negative Bacteria | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antimicrobials a | S (%) | I (%) | R (%) | S (%) | I (%) | R (%) | S (%) | I (%) | R (%) | S (%) | I (%) | R (%) |
| Amoxicillin/clavulanic-acid | 91.3 | - | 8.7 | 92.3 | 7.7 | - | - | - | 100 | 50 | 25 | 25 |
| Cefazolin | 65.3 | 21.7 | 13 | 7.7 | 7.7 | 84.6 | - | - | 100 | 25 | - | 75 |
| Cefoxitin | 100 | - | - | 92.3 | - | 7.7 | M b | - | - | 100 | - | - |
| Ceftiofur | 95.7 | - | 4.3 | 92.3 | - | 7.7 | M b | - | - | 100 | - | - |
| Cefepime | 100 | - | - | 100 | - | - | 100 | - | - | 100 | - | - |
| Gentamicin | 87 | 4.3 | 8.7 | 100 | - | - | - | - | 100 | 100 | - | - |
| Amikacin | 100 | - | - | 100 | - | - | 100 | - | - | 100 | - | - |
| Kanamycin | 100 | - | - | 100 | - | - | M b | - | - | 75 | 25 | - |
| Tetracycline | 87 | - | 13 | 92.3 | - | 7.7 | NA c | NA c | NA c | 75 | 25 | - |
| Tigecycline | 95.7 | 4.3 | - | 92.3 | - | 7.7 | NA c | NA c | NA c | 100 | - | - |
| Enrofloxacin | M b | - | - | M b | - | - | M b | - | - | M b | - | - |
| Trimethoprim-Sulfamethoxazole | 95.7 | 4.3 | - | 92.3 | - | 7.7 | 85.7 | - | 14.3 | 100 | - | - |
| Meropenem | 100 | - | - | 100 | - | - | 100 | - | - | 100 | - | - |
| Rifampicin | M b | - | - | M b | - | - | M b | - | - | M b | - | - |
a, S = sensitive, I = intermediate, R = resistant. b, M = only MIC50 and MIC90 value were provided. Data were presented in this way when there was no break point to refer to, according to CLSI [27]. c, NA = not applicable. P. aeruginosa was intrinsically resistant to tetracyclines according to EUCAST. Antimicrobial susceptibility to these agents were not evaluated for P. aeruginosa [31].
Antimicrobial susceptibility of SEZ isolates collected from the uteruses of 30 donkeys at ECDC between 2018 and 2021.
| Gram-Positive Bacteria | |||
|---|---|---|---|
| Antimicrobials a | S (%) | I (%) | R (%) |
| Amoxicillin/clavulanic-acid | 100 | - | - |
| Cefoxitin | M b | - | - |
| Ceftiofur | 100 | - | - |
| Cefepime | 100 | - | - |
| Gentamicin | - | 33.3 | 66.7 |
| Amikacin | 66.7 | 33.3 | - |
| Kanamycin | M b | - | - |
| Tigecycline | 100 | - | - |
| Erythromycin | 100 | - | - |
| Enrofloxacin | Mb | - | - |
| Trimethoprim-Sulfamethoxazole | 100 | - | - |
| Meropenem | 100 | - | - |
| Vancomycin | 100 | - | - |
| Rifampicin | 100 | - | - |
a, S = sensitive, I = intermediate, R = resistant. b, M = only MIC50 and MIC90 value were provided. Data were presented in that way when there was no break point to refer to, according to CLSI.
MIC values of bacteria isolated from the uteruses of 30 donkeys at ECDC between 2018 and 2021.
| Bacteria |
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| MIC Values (μg/mL) | MIC50 | MIC90 | MIC50 | MIC90 | MIC50 | MIC90 | MIC50 | MIC90 | MIC50 | MIC90 |
| Cefoxitin | - | - | - | - | >128 | >128 | - | - | <0.25 | <0.25 |
| Ceftiofur | - | - | - | - | 32 | 32 | - | - | - | - |
| Kanamycin | - | - | - | - | >128 | >128 | - | - | 32 | 32 |
| Enrofloxacin | <0.25 | 1 | <0.25 | 1 | 8 | 8 | <0.25 | <0.25 | 1 | 1 |
| Rifampicin | 4 | 8 | <0.25 | 0.5 | >128 | >128 | 16 | 64 | - | - |